Actualités Medtox Scientific, Inc. (MM) - MTOX | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

- (25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...

- Quarterly Report (10-Q)

FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy...

MEDTOX Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition by LabCorp

ST. PAUL, Minn., July 20, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT...

Acquisition of MEDTOX by LabCorp Clears Antitrust Approval

ST. PAUL, Minn., July 13, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

MEDTOX Scientific Announces Second Quarter Results

ST. PAUL, Minn., July 12, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced...

- Amended Statement of Ownership (SC 13G/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2...

- Amended Statement of Ownership (SC 13G/A)

Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) Medtox...

- Statement of Beneficial Ownership (SC 13D)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medtox Scientific, Inc. (MM) (MTOX)

Outils de qualité professionnelle, pour des investisseurs individuels.

MTOX Actualités

- (25-NSE)

- Quarterly Report (10-Q)

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition by LabCorp

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

Acquisition of MEDTOX by LabCorp Clears Antitrust Approval

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Scientific Announces Second Quarter Results

- Amended Statement of Ownership (SC 13G/A)

- Amended Statement of Ownership (SC 13G/A)

- Statement of Beneficial Ownership (SC 13D)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medtox Scientific, Inc. (MM) (MTOX) Actualités

Medtox Scientific, Inc. (MM) (MTOX)

Outils de qualité professionnelle, pour des investisseurs individuels.

MTOX Actualités

- (25-NSE)

- Quarterly Report (10-Q)

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition by LabCorp

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

Acquisition of MEDTOX by LabCorp Clears Antitrust Approval

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Scientific Announces Second Quarter Results

- Amended Statement of Ownership (SC 13G/A)

- Amended Statement of Ownership (SC 13G/A)

- Statement of Beneficial Ownership (SC 13D)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres